HUP9700826A1 - Peptikus fekély elleni gyógyászati készítmények - Google Patents

Peptikus fekély elleni gyógyászati készítmények

Info

Publication number
HUP9700826A1
HUP9700826A1 HU9700826A HUP9700826A HUP9700826A1 HU P9700826 A1 HUP9700826 A1 HU P9700826A1 HU 9700826 A HU9700826 A HU 9700826A HU P9700826 A HUP9700826 A HU P9700826A HU P9700826 A1 HUP9700826 A1 HU P9700826A1
Authority
HU
Hungary
Prior art keywords
peptic ulcer
pharmaceutical compositions
compositions against
against peptic
production
Prior art date
Application number
HU9700826A
Other languages
English (en)
Inventor
János Illés
Judit Matúz
Erzsébet Neszmélyi
Béla Stefkó
Gáborné Forrai
László Szporny
Katalin Sághy
Original Assignee
Richter Gedeon Vegyészeti Gyár Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyészeti Gyár Rt. filed Critical Richter Gedeon Vegyészeti Gyár Rt.
Priority to HU9700826A priority Critical patent/HU225991B1/hu
Publication of HU9700826D0 publication Critical patent/HU9700826D0/hu
Priority to EP98920684A priority patent/EP1017403B1/en
Priority to PL98336482A priority patent/PL189526B1/pl
Priority to PCT/HU1998/000044 priority patent/WO1998048815A1/en
Priority to DE69833937T priority patent/DE69833937T2/de
Priority to IL13221498A priority patent/IL132214A0/xx
Priority to ES98920684T priority patent/ES2259813T3/es
Priority to CN98804672A priority patent/CN1126548C/zh
Priority to SK1468-99A priority patent/SK284864B6/sk
Priority to EEP199900470A priority patent/EE04953B1/xx
Priority to DK98920684T priority patent/DK1017403T3/da
Priority to SI9830830T priority patent/SI1017403T1/sl
Priority to AT98920684T priority patent/ATE320814T1/de
Priority to BR9809354-1A priority patent/BR9809354A/pt
Priority to KR1019997010037A priority patent/KR100572190B1/ko
Priority to UA99116468A priority patent/UA62964C2/uk
Priority to TW087106525A priority patent/TW501927B/zh
Priority to EA199900983A priority patent/EA002134B1/ru
Priority to CA002286756A priority patent/CA2286756C/en
Priority to US09/403,714 priority patent/US6656921B1/en
Priority to CZ0382799A priority patent/CZ297317B6/cs
Priority to AU73468/98A priority patent/AU749757B2/en
Priority to JP54638898A priority patent/JP2001522361A/ja
Priority to PT98920684T priority patent/PT1017403E/pt
Priority to NZ500978A priority patent/NZ500978A/en
Priority to ZA983626A priority patent/ZA983626B/xx
Publication of HUP9700826A1 publication Critical patent/HUP9700826A1/hu
Priority to BG103822A priority patent/BG64458B1/bg
Priority to NO19995229A priority patent/NO328313B1/no
Priority to HK00104494A priority patent/HK1025250A1/xx
Publication of HU225991B1 publication Critical patent/HU225991B1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya peptikűs fekély elleni gyógyszerkészítmény,valamint eljárás ezek előállítására. A találmány szerinti gyógyászatikészítmények hatóanyagként cink-hialűrőnát asszőciátűmőt/kőmplexet),és önmagában ismert, a gyógyászati készítmények előállításánálszőkásősan alkalmazőtt hőrdőzó és/vagy segédanyagőkat tartalmaznak. ŕ
HU9700826A 1996-09-12 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer HU225991B1 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
HU9700826A HU225991B1 (en) 1997-04-29 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
NZ500978A NZ500978A (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate complex against peptic ulcer
KR1019997010037A KR100572190B1 (ko) 1997-04-29 1998-04-28 소화성궤양에 대한 아연 히알루로네이트의 사용
TW087106525A TW501927B (en) 1997-04-29 1998-04-28 Pharmaceutical compositions against peptic ulcer
PL98336482A PL189526B1 (pl) 1997-04-29 1998-04-28 Farmaceutyczna kompozycja do stosowania doustnegoprzeciw wrzodowi trawiennemu, sposób wytwarzania farmaceutycznej kompozycji oraz zastosowanie asocjatu hialuronianu cynkowego do wytwarzania farmaceutycznej kompozycji
DE69833937T DE69833937T2 (de) 1997-04-29 1998-04-28 Verwendung von zinkhyaluronat gegen magengeschwür
IL13221498A IL132214A0 (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate against peptic ulcer
ES98920684T ES2259813T3 (es) 1997-04-29 1998-04-28 Utilizacion del hialuronato de zinc contra la ulcera peptica.
CN98804672A CN1126548C (zh) 1997-04-29 1998-04-28 透明质酸锌抗消化性溃疡的应用
SK1468-99A SK284864B6 (sk) 1997-04-29 1998-04-28 Použitie komplexu hyaluronátu zinku na prípravu farmaceutickej kompozície proti peptickým vredom
EEP199900470A EE04953B1 (et) 1997-04-29 1998-04-28 Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks
DK98920684T DK1017403T3 (da) 1997-04-29 1998-04-28 Anvendelse af zinkhyaluronat mod peptisk ulcer
SI9830830T SI1017403T1 (sl) 1997-04-29 1998-04-28 Uporaba cinkovega hialuronata proti pepticnemu ulkusu
AT98920684T ATE320814T1 (de) 1997-04-29 1998-04-28 Verwendung von zinkhyaluronat gegen magengeschwür
BR9809354-1A BR9809354A (pt) 1997-04-29 1998-04-28 Uso de hialuronato de zinco contra úlcera péptica
EP98920684A EP1017403B1 (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate against peptic ulcer
UA99116468A UA62964C2 (en) 1997-04-29 1998-04-28 Pharmaceutical compositions against peptic ulcer, manufacture process, and method for treating peptic ulcer
PCT/HU1998/000044 WO1998048815A1 (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate against peptic ulcer
EA199900983A EA002134B1 (ru) 1997-04-29 1998-04-28 Применение комплекса гиалуроната цинка для лечения пептической язвы
CA002286756A CA2286756C (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate against peptic ulcer
US09/403,714 US6656921B1 (en) 1997-04-29 1998-04-28 Use of zinc hyaluronate against peptic ulcer
CZ0382799A CZ297317B6 (cs) 1997-04-29 1998-04-28 Farmaceutická kompozice pro orální pouzití proti peptickému vredu
AU73468/98A AU749757B2 (en) 1996-09-12 1998-04-28 Use of zinc hyaluronate against peptic ulcer
JP54638898A JP2001522361A (ja) 1997-04-29 1998-04-28 消化性潰瘍に対するヒアルロン酸亜鉛の利用
PT98920684T PT1017403E (pt) 1997-04-29 1998-04-28 Utilizacao de hialuronato de zinco contra a ulcera peptica
ZA983626A ZA983626B (en) 1997-04-29 1998-04-29 Pharmaceutical compositions against peptic ulcer
BG103822A BG64458B1 (bg) 1997-04-29 1999-10-19 Използване на цинков хиалуронат срещу пептична язва
NO19995229A NO328313B1 (no) 1997-04-29 1999-10-26 Fremgangsmate for fremstilling av et farmasoytisk preparat for oral anvendelse mot peptisk ulcus og anvendelse av sinkhyaluronatassosiat (-kompleks) med en molekylvekt i omradet fra 500 000 dalton til 1 200 000 dalton for fremstilling av farmasoytiske preparater for oral anvendelse mot peptisk ulcus
HK00104494A HK1025250A1 (en) 1997-04-29 2000-07-20 Use of zinc hyaluronate against peptic ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700826A HU225991B1 (en) 1997-04-29 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Publications (3)

Publication Number Publication Date
HU9700826D0 HU9700826D0 (en) 1997-06-30
HUP9700826A1 true HUP9700826A1 (hu) 1998-12-28
HU225991B1 HU225991B1 (en) 2008-02-28

Family

ID=89995068

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700826A HU225991B1 (en) 1996-09-12 1997-04-29 Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Country Status (27)

Country Link
US (1) US6656921B1 (hu)
EP (1) EP1017403B1 (hu)
JP (1) JP2001522361A (hu)
KR (1) KR100572190B1 (hu)
CN (1) CN1126548C (hu)
AT (1) ATE320814T1 (hu)
BG (1) BG64458B1 (hu)
BR (1) BR9809354A (hu)
CA (1) CA2286756C (hu)
CZ (1) CZ297317B6 (hu)
DE (1) DE69833937T2 (hu)
DK (1) DK1017403T3 (hu)
EA (1) EA002134B1 (hu)
EE (1) EE04953B1 (hu)
ES (1) ES2259813T3 (hu)
HK (1) HK1025250A1 (hu)
HU (1) HU225991B1 (hu)
IL (1) IL132214A0 (hu)
NO (1) NO328313B1 (hu)
NZ (1) NZ500978A (hu)
PL (1) PL189526B1 (hu)
PT (1) PT1017403E (hu)
SK (1) SK284864B6 (hu)
TW (1) TW501927B (hu)
UA (1) UA62964C2 (hu)
WO (1) WO1998048815A1 (hu)
ZA (1) ZA983626B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
US8057294B2 (en) * 2005-09-09 2011-11-15 Wms Gaming Inc. Wagering game system with community gaming system
CN100355790C (zh) * 2005-11-04 2007-12-19 山东福瑞达生物化工有限公司 一种透明质酸锌的制备方法
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
CN101023961B (zh) * 2006-02-23 2010-07-21 山东省生物药物研究院 一种含透明质酸钠和锌盐的药物组合物
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
TWI516269B (zh) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
TWI383796B (zh) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
ES2388281B1 (es) * 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
WO2013129577A1 (ja) * 2012-03-01 2013-09-06 キユーピー株式会社 TGF-β発現促進経口剤、痛み物質産生抑制経口剤及び浮腫抑制経口剤
US20160287627A1 (en) * 2013-11-22 2016-10-06 Kewpie Corporation Method for suppressing onset of gastric ulcer as adverse effect of drug, oral pharmaceutical composition for suppressing onset of gastric ulcer and method for producing the same
CN104262499A (zh) * 2014-09-03 2015-01-07 佐源集团有限公司 一种低聚果糖锌及含有低聚果糖锌的口服液
CN108051553A (zh) * 2017-12-29 2018-05-18 武汉轻工大学 一种仔猪肠道功能保护剂的筛选方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
AU600483B2 (en) * 1986-03-14 1990-08-16 Bio-Technology General Corporation Heavy metal salts of hyaluronic acid
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US6458774B1 (en) * 1989-02-24 2002-10-01 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing hyaluronic acid associates and a process for preparing same
US5472950A (en) 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
HU225991B1 (en) 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer

Also Published As

Publication number Publication date
PL189526B1 (pl) 2005-08-31
KR20010020413A (ko) 2001-03-15
WO1998048815A1 (en) 1998-11-05
HU9700826D0 (en) 1997-06-30
SK146899A3 (en) 2000-06-12
PL336482A1 (en) 2000-06-19
CN1254285A (zh) 2000-05-24
DE69833937T2 (de) 2007-06-06
CA2286756C (en) 2008-02-19
EP1017403A1 (en) 2000-07-12
CZ382799A3 (cs) 2000-03-15
IL132214A0 (en) 2001-03-19
CA2286756A1 (en) 1998-11-05
SK284864B6 (sk) 2006-01-05
CN1126548C (zh) 2003-11-05
ES2259813T3 (es) 2006-10-16
US6656921B1 (en) 2003-12-02
ATE320814T1 (de) 2006-04-15
TW501927B (en) 2002-09-11
CZ297317B6 (cs) 2006-11-15
JP2001522361A (ja) 2001-11-13
NO995229D0 (no) 1999-10-26
BR9809354A (pt) 2000-07-04
NZ500978A (en) 2001-05-25
NO328313B1 (no) 2010-01-25
BG64458B1 (bg) 2005-03-31
EP1017403B1 (en) 2006-03-22
EE9900470A (et) 2000-06-15
UA62964C2 (en) 2004-01-15
EA199900983A1 (ru) 2000-08-28
ZA983626B (en) 1998-11-05
BG103822A (en) 2000-04-28
DE69833937D1 (de) 2006-05-11
PT1017403E (pt) 2006-07-31
HK1025250A1 (en) 2000-11-10
NO995229L (no) 1999-12-22
EA002134B1 (ru) 2001-12-24
DK1017403T3 (da) 2006-07-31
KR100572190B1 (ko) 2006-04-18
HU225991B1 (en) 2008-02-28
EE04953B1 (et) 2008-02-15

Similar Documents

Publication Publication Date Title
HUP9700826A1 (hu) Peptikus fekély elleni gyógyászati készítmények
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
FI964681A (fi) Ihmisperäiset Lactobacillus-kannat, niitä sisältävät valmisteet ja niiden käytöt
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
TR200101412T2 (tr) Yeni bileşikler.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
FI945081A0 (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
NL192721B (nl) Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten.
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DK1167354T3 (da) Racemisk huperzin A
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
TR200100637T2 (tr) Yeni doğal ürün türevleri
BR0013106A (pt) Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.
MXPA04005552A (es) Analogos de vitamina d.
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ZA979650B (en) Heterocyclic compounds, compositions and uses.

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: RICHTER GEDEON NYRT., HU

Free format text: FORMER OWNER(S): RICHTER GEDEON VEGYESZETI GYAR RT., HU